Biosensors El mercat es va valorar 26.24 mil milions de dòlars in 2021. By 2031, it is expected to reach 54.21 mil milions de dòlars. This market is expected to grow at a CAGR de 8.56% entre 2022 i 2031.
La demanda està creixent
However, the market’s dynamic is affected by many factors. Global market research on biosensors indicates that the increasing demand for point-of-care testing drives the demand for biosensors. Consumers are encouraged to use biosensors to detect potential pathogenic activities in their bodies, especially if they have chronic or lifestyle-related conditions. This is expected to increase the demand for biosensors. Due to the notable increase in the global elderly population and the expansion of nanotechnology, biosensor applications are growing. They are also more affordable.
Obteniu una mostra d'un informe per obtenir una visió completa @ https://market.us/report/biosensors-market/request-sample/
Biosensors incorporate nanotechnology and are expected to have lucrative applications in many industrial activities like food analysis, imaging operations, and monitoring microbial activity. Market consolidation is due to increasing demand for tailored medical equipment, non-invasive biosensors, and increased collaboration between manufacturers. Ethicon Endo-Surgery Inc. entered into a contract with Johnson & Johnson Innovation to partner with Biometrics BrainStem Inc. Ethicon will also use several co-funding mechanisms to verify the operational and clinical efficacy Biometrics BrainStem Tremor Monitor Unit. It is a small, non-invasive medical device that detects very minute eye movements of anesthesia patients.
Factors conductors
Many factors have influenced the market for biosensors. These include the emergence of nanotechnology-based sensors, technological advancements over the past few years, and the increasing use of biosensors for monitoring glucose levels in people with diabetes. Also, there is a surge in demand for home-based point-of-care devices due to the COVID-19 epidemic.
Factors restrictius
The market for biosensors has seen a significant increase in demand for integrated point-of-care and portable devices. These devices are easily accessible to patients and offer quick results. There is more demand, which has led to increased growth. Market growth is slowed by safety concerns and strict regulations regarding biosensors used in homes and laboratories.
To maintain market growth, the rapid proliferation of biosensors in areas like medicine, agriculture, and monitoring will dominate. The market growth will be limited by restrictions from the government and less research on the subject.
Tendències clau del mercat
A platform developed by scientists at the University of California San Diego can detect DNA mutations with extremely high sensitivity. A large research group, led by the Center of Excellence for Nanomedicine and Engineering, created a sensor that can identify single-nucleotide polymorphisms in DNA sequences. SNPs can be described as variations in the sequence of a single nucleotide of a gene. This mutation has been linked with various disorders, including cancer, heart disease, and autoimmune diseases.
Researchers used a synthesized DNA sequence to encapsulate the graphene field effect transistor. The electrical signal generated by DNA or RNA sequences that contain SNP mutations is called a “DNA” signal. This biosensor, according to scientists, is a prototype for an implantable device that can identify SNPs or genetic alterations in real-time and notify users via their mobile phones.
Desenvolupament recent
- Roche and Sysmex entered into a Global Business Partnership Agreement (GBP) in January 2021. This agreement provides hematology testing solutions. The new agreement will use IT systems to improve clinical decision-making and customer experience. This long-standing, successful partnership continues to evolve to bring hematology testing innovations worldwide.
- Abbott, a company that makes sensor-based glucose monitoring devices, announced FreeStyle Libre 2, its next generation, in December 2020. Health Canada approved this technology to monitor diabetes in adults and children aged four years.
- Bio-Rad Laboratories announced in December 2020 that they would expand their joint marketing agreement with Siemens Healthineers. Bio-Rad Labs will now provide quality control products and Unity Quality Control data management solutions to Siemens Healthineers’ Atellica Solution platforms.
- Medtronic’s InPen was launched in November 2020 with real-time Guardian Connect CGM information. InPen, the FDA-cleared smart pen for insulin, is available to people on multiple daily injections (MDI).
- Bio-Rad Laboratories, in October 2020, announced the global launch of its CFX Opus 96 PCR Systems. It also introduced BR.io cloud-based instrument connectivity and data management.
- Medtronic received approval from the US Food and Drug Administration in September 2020 for the MiniMed 770G closed-loop hybrid system. The company’s latest insulin pump system includes the most advanced SmartGuard technology (as featured in the MiniMed670G system), with additional benefits such as smartphone connectivity and an expanded age indication, down to 2 years old.
- Tandem Diabetes Care and Abbott signed an agreement to develop and market integrated diabetes solutions. This combines Abbott’s world-leading continuous glucose monitor (CGM) technology and Tandem’s innovative insulin delivery methods to give people more options in managing their diabetes.
Empreses clau
- Abbott Point of Care Inc. (US)
- Medtronic, Inc. (US)
- F.Hoffman-La Roche Ltd. (Switzerland)
- Siemens AG (Alemanya)
- LifeScan,Inc.(US)
- LifeSensors Inc.(US)
- Nova Biomedical Corp.(US)
- Acon Laboratories Inc.(US)
- Universal Biosensors (Australia)
- Pharmaco-Kinesis Corporation (PKC) (US)
- Bayer Healthcare AG (Germany)
- Biacore (UK)
- Bio-Rad Laboratories Inc.(US)
- Biosensors International Ltd.(Singapore)
- Ercon,Inc(US)
- DuPont(US)
- Sysmex Corporation (Japan)
Segments clau del mercat:
Tipus
- Punt d'Atenció
- Home Diagnostics
- Laboratoris d’investigació
- Biodefense
Sol·licitud
- Electrochemical Biosensors
- Piezoelectric Biosensors
- Optical Biosensors
- Thermal Biosensors
Preguntes freqüents
- What is the size of the current market for biosensors in the United States?
- What will the CAGR be for the global biosensors industry?
- Which are the main players in the market for biosensors?
- Which are the main driving factors for the biosensors industry?
- Which region will dominate the global market for biosensors?
Informe relacionat:
Global Glucose Biosensors Market Jugadors clau Visió general del sector Oferta i consum Demanda i previsió fins al 2031
Global Biosensors for Point-of-Care Testing Market Anàlisi i investigació en profunditat sobre les tendències de la dinàmica de la indústria Factors de creixement emergents i previsió 2031
Global Nano Biosensors Market Creixement per fabricants, regions, tipus i aplicació, previsió fins al 2031
Global Piezoelectric Biosensors Market Major Manufacturers Production And Sales Industry Comparison Analysis, Types And Application
Global Medical Biosensors Market Recerca jugadors clau Visió general del sector Anàlisi i previsió de la cadena de subministrament fins al 2031
Global Bioelectronics and Biosensors Market Factors de creixement de la indústria, tipus i aplicacions Anàlisi regional Jugadors clau i previsió per al 2031
Sobre Market.us
Market.US (Powered by Prudour Private Limited) s'especialitza en investigacions i anàlisis en profunditat. Aquesta empresa ha demostrat ser una consultora líder i un investigador de mercat personalitzat i un proveïdor d'informes d'investigació de mercat molt respectat.
Detalls de contacte:
Equip de desenvolupament empresarial global: Market.us
Market.us (proporcionat per Prudour Pvt. Ltd.)
Adreça: 420 Lexington Avenue, Suite 300 Nova York, NY 10170, Estats Units
Telèfon: +1 718 618 4351 (Internacional), Telèfon: +91 78878 22626 (Àsia)
Correu electrònic: [protegit per correu electrònic]
QUÈ TREURE D'AQUEST ARTICLE:
- This biosensor, according to scientists, is a prototype for an implantable device that can identify SNPs or genetic alterations in real-time and notify users via their mobile phones.
- A large research group, led by the Center of Excellence for Nanomedicine and Engineering, created a sensor that can identify single-nucleotide polymorphisms in DNA sequences.
- SNPs can be described as variations in the sequence of a single nucleotide of a gene.
